Helyx Industries S.p.A. (HLX)
MTA
Closed
Sep 18, 2026
Day's Range
0.742052 wk Range
0.5600Overview - HLX - Helyx Industries S.p.A.
Key Statistics
Valuation
Enterprise Value
19.34M
P/E (Forward)
‪748.00‬
PEG Ratio
‪748.00‬
Price / Sales (TTM)
‪10.23‬
Price / Book
‪0.96‬
EV / EBITDA
‪-12.34‬
Profitability
Profit Margin
‪-226.50%‬
Operating Margin
‪-144.28%‬
Return on Assets
‪-10.97%‬
Return on Equity
‪-19.97%‬
Ownership
Shares Outstanding
26.04M
Held by Insiders
‪33.16%‬
Held by Institutions
‪7.06%‬
Price stats
Beta
‪0.74‬
50-Day Avg
‪0.7178‬
200-Day Avg
‪0.7279‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪€ 1.17‬Market Cap - HLX - Helyx Industries S.p.A.
Peers - HLX - Helyx Industries S.p.A.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- HLHLXMTAHelyx Industries S.p.A.20.94MMarket Cap-8.29%52-week change—P/E (Trailing)‪-226.50%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+24.90%52-week change30.14P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.24%52-week change19.66P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-79.10%52-week change43.72P/E (Trailing)‪16.12%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap-12.34%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change44.69P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+30.82%52-week change15.59P/E (Trailing)‪27.70%‬Profit Margin
Profile Summary - HLX - Helyx Industries S.p.A.
About
Helyx Industries S.p.A. is an Italian healthcare biotechnology company specializing in genetics-driven medical solutions. The company focuses on developing innovative diagnostic and theranostic platforms designed to improve disease detection, patient monitoring, and personalized treatment pathways. Its technologies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
